![[Video] The Weekly Break Out Ep. 19: Army aviation’s shakeup and the F-35’s future](https://breakingdefense.com/wp-content/uploads/sites/3/2025/05/EP-19-THUMB-play-button.jpg?#)
Big Pharma-backed GlycoEra counting days to clinic with $130M raise for protein degraders
It’s GlycoEra’s time to shine. The biotech has closed a series B fundraise clocking in at $130 million, with the funds set to support clinical trials for the company’s lead autoimmune protein degrader later this year.
It’s GlycoEra’s time to shine. The biotech has closed a series B fundraise clocking in at $130 million, with the funds set to support clinical trials for the company’s lead autoimmune protein degrader later this year.
